CVC  Amgen Ventures

https://www.amgenbd.com/





     Office Locations:

One Amgen Center Drive
Thousand Oaks, CA 91320-1799
Phone: 805-447-1000
Fax: 805-447-1010

Get all office locations for this firm with a National Database subscription or Silicon Valley Database subscription.
 

Stages:

  • Early


 

Industries:

  • Life Sciences & Healthcare

  •  

    Description:

    A division of biotech giant Amgen, Amgen Ventures funds early-stage companies developing human therapeutics. The Fund was founded in 2004 with an initial $100 million investment. While the fund's focus is primarily in areas of current therapeutic interest to Amgen, it also seeks out novel modalities with the potential to address targets in both current and emerging therapeutic areas of interest. Investments are made on a case-by-case basis, but Amgen Ventures typically invests $2 to 3 million per company per round with $10 million invested over the life of the company. Therapeutic areas of focus for Amgen include: Oncology, Inflammation, Hematology/Nephrology, Metabolic Disorders, Neuroscience and Cardiovascular. Amgen primarily invests in North America, but will consider investments in Europe and the United Kingdom.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Gladys Nunez Principal
    Janis Naeve Managing Director
    Jeremy Grunstein Executive Director
    Jessica Droge Executive Director
    Ray Barlow Executive Director

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      08/09/2018


      Akili Interactive


      


      $13,000,000


      Series C


      05/09/2018


      Akili Interactive Labs


      MA


      $55,000,000


      Series C


      04/11/2018


      Aetion


      NY


      $36,000,000


      Series B


      02/27/2018


      Senti Biosciences


      CA


      $53,000,000


      


      12/06/2017


      Obsidian Therapeutics


      MA


      $49,500,000


      Series A


      11/14/2017


      Syapse


      CA


      $30,000,000


      Series D


      10/30/2017


      Kymera Therapeutics


      MA


      $30,000,000


      Series A


      08/23/2017


      GNS Healthcare


      MA


      $6,000,000


      


     

    Portfolio companies include:


      Accelerator
        web link


      Aetion
        web link


      Akili Interactive


      Akili Interactive Labs
        web link


      Alector
        web link


      Allozyne
        web link


      Atara Biotherapeutics
        web link


      Calistoga
        web link


      DecImmune Therapeutics
        web link


      Epizyme
        web link


      GNS Healthcare
        web link


      Imago BioSciences
        web link


      Kymera Therapeutics
        web link


      miRagen
        web link


      Mirina Corp.
        web link


      NexImmune
        web link


      Obsidian Therapeutics
        web link


      Precision BioSciences
        web link


      Senti Biosciences
        web link


      SiteOne Therapeutics
        web link


      Surface Oncology
        web link


      Sutro Biopharma
        web link


      Syapse
        web link


      Synovex
        web link


      TetraLogic
        web link


      Theraclone Sciences
        web link


      Tizona Therapeutics
        web link


      Trinity Biosystems
        web link


      VLST
        web link


      Xori Corp.
        web link


     

    Recent News: